Xometry financials
$104.23+1.06%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $686.6M | $545.5M | $463.4M | $380.9M | $218.3M |
| Gross profit | $268.8M | $215.6M | $178.3M | $146.0M | $57.1M |
| Gross margin | 39.1% | 39.5% | 38.5% | 38.3% | 26.2% |
| Operating income | -$45.5M | -$56.1M | -$73.6M | -$77.1M | -$58.7M |
| Net income | -$61.7M | -$50.4M | -$67.5M | -$79.1M | -$61.4M |
| Net margin | −9.0% | −9.2% | −14.6% | −20.8% | −28.1% |
| Diluted EPS | $-1.22 | $-1.03 | $-1.41 | $-1.68 | $-2.33 |
| EBITDA | -$26.7M | -$43.1M | -$62.4M | -$68.4M | -$54.0M |
| Operating cash flow | $6.1M | -$15.4M | -$29.9M | -$62.6M | -$68.6M |
| Free cash flow | -$24.1M | -$33.5M | -$48.4M | -$76.2M | -$74.8M |
| Diluted shares | 50.8M | 49.1M | 47.9M | 47.2M | 26.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $15.0M | $22.2M | $53.4M | $65.7M | $86.3M |
| Short-term investments | $204.1M | $217.6M | $215.4M | $253.8M | $30.5M |
| Total debt | $327.5M | $283.6M | $281.8M | $279.9M | $2.0K |
| Total assets | $703.7M | $680.1M | $707.4M | $734.1M | $502.6M |
| Total liabilities | $427.0M | $364.5M | $377.0M | $362.3M | $77.1M |
| Shareholders' equity | $276.7M | $315.6M | $330.4M | $371.8M | $425.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology